Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)745-748
Number of pages4
JournalBone marrow transplantation
Issue number3
StatePublished - Mar 2021

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this